These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6091579)

  • 1. Locomotor depression by the opioid benzodiazepine tifluadom in mice.
    Castellano C; Pavone F; Sansone M
    Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):318-23. PubMed ID: 6091579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of kappa-opioid receptor agonists on locomotor activity and memory processes in mice.
    Castellano C; Ammassari-Teule M; Libri V; Pavone F
    Pol J Pharmacol Pharm; 1988; 40(5):507-13. PubMed ID: 2855367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid benzodiazepine tifluadom and drug-induced hyperactivity in mice: lack of benzodiazepine-like effects.
    Sansone M; Castellano C; Pavone F; Hano J
    Pol J Pharmacol Pharm; 1985; 37(5):585-90. PubMed ID: 2870483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the selective kappa-opioid receptor agonist U-50,488 on locomotor activity and passive avoidance behaviour in DBA/2 and C57BL/6 mice.
    Castellano C; Pavone F
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):270-80. PubMed ID: 2823735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the opioid benzodiazepine tifluadom and its optical isomers on spontaneous locomotor activity of mice.
    Ruhland M; Zeugner H
    Life Sci; 1983; 33 Suppl 1():631-4. PubMed ID: 6319918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bremazocine on locomotor activity in DBA/2 and C57BL/6 mice.
    Castellano C; Pavone F
    Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):45-52. PubMed ID: 4096608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between narcotic analgesics and benzodiazepine derivatives on behavior in the mouse.
    Shannon HE; Holtzman SG; Davis DC
    J Pharmacol Exp Ther; 1976 Nov; 199(2):389-99. PubMed ID: 10428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
    Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N
    J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-dependent behavioral sensitivity to mu vs. kappa opiate agonists. I. Acute and chronic effects on mouse locomotor activity.
    Gwynn GJ; Domino EF
    J Pharmacol Exp Ther; 1984 Nov; 231(2):306-11. PubMed ID: 6092613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
    Vaught JL; Mathiasen JR; Raffa RB
    J Pharmacol Exp Ther; 1988 Apr; 245(1):13-6. PubMed ID: 2834533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of the two isomers of the opioid benzodiazepine tifluadom with mu-, delta-, and kappa-binding sites and their analgesic and intestinal effects in rats.
    Petrillo P; Amato M; Tavani A
    Neuropeptides; 1985 Feb; 5(4-6):403-6. PubMed ID: 2860598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
    Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral effects of opioid subtypes compared with benzodiazepines in the staircase paradigm.
    Milman A; Weizman R; Rigai T; Rice KC; Pick CG
    Behav Brain Res; 2006 Jun; 170(1):141-7. PubMed ID: 16574254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-dependent behavioral sensitivity to mu vs. kappa opiate agonists. II. Antinociceptive tolerance and physical dependence.
    Gwynn GJ; Domino EF
    J Pharmacol Exp Ther; 1984 Nov; 231(2):312-6. PubMed ID: 6092614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The difference in stress-induced analgesia in C57BL/6 and DBA/2 mice: a search for biochemical correlates.
    Przewłocka B; Vetulani J; Lasoń W; Dziedzicka M; Silberring J; Castellano C; Przewłocki R
    Pol J Pharmacol Pharm; 1988; 40(5):497-506. PubMed ID: 2908136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid receptor selectivity of heroin given intracerebroventricularly differs in six strains of inbred mice.
    Rady JJ; Elmer GI; Fujimoto JM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):438-45. PubMed ID: 9918543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [D-Pro10]-dynorphin(1-11) is a kappa-selective opioid analgesic in mice.
    Gairin JE; Gout R; Meunier JC; Cros J
    J Pharmacol Exp Ther; 1988 Jun; 245(3):995-1001. PubMed ID: 2898527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa opioid receptor activity in spontaneously hypertensive rats.
    Bhargava HN; Gulati A
    J Pharmacol Exp Ther; 1988 May; 245(2):460-5. PubMed ID: 2835473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mu opioid analgesia and analgesic tolerance in two mouse strains: C57BL/6 and 129/SvJ.
    Varnado-Rhodes Y; Gunther J; Terman GW; Chavkin C
    Proc West Pharmacol Soc; 2000; 43():15-7. PubMed ID: 11056944
    [No Abstract]   [Full Text] [Related]  

  • 20. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.